REPORTS

Let’s Pullulate and Expand Your Business

Angina Pectoris Treatment Market - Global Professional Analysis and Forecast to 2026

Nov 01, 2019  |  222 PAGES  |  REPORT CODE: CMM226298
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Angina Pectoris Treatment market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.7% during the forecast period.

This report presents the market size and development trends by detailing the Angina Pectoris Treatment market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Angina Pectoris Treatment market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Angina Pectoris Treatment industry and will help you to build a panoramic view of the industrial development.

Angina Pectoris Treatment Market, By Type:

  • Antiplatelet agents

  • Beta-adrenergic blocking agents

  • Calcium channel blockers

  • Short & Long – acting Nitroglycerines

  • Angiotensin-converting enzyme (ACE) inhibitors

  • Anti-ischemic agents

Angina Pectoris Treatment Market, By Application:

  • Hospitals

  • Clinic

  • Other

Some of the leading players are as follows:

  • Bristol-Myers Squibb Company

  • Bayer AG

  • Astra Zeneca plc

  • Abbott Laboratories Inc.

  • F. Hoffmann-La Roche Ltd

  • Forest Laboratories Inc

  • Sanofi SA

  • Pfizer Inc.

  • Gilead Sciences, Inc

  • Novartis AG

  • GlaxoSmithKline plc

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Angina Pectoris Treatment Market: Technology Type Analysis

  • 4.1 Angina Pectoris Treatment Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Angina Pectoris Treatment Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Antiplatelet agents

    • 4.3.2 Beta-adrenergic blocking agents

    • 4.3.3 Calcium channel blockers

    • 4.3.4 Short & Long – acting Nitroglycerines

    • 4.3.5 Angiotensin-converting enzyme (ACE) inhibitors

    • 4.3.6 Anti-ischemic agents

5 Angina Pectoris Treatment Market: Product Analysis

  • 5.1 Angina Pectoris Treatment Product Market Share Analysis, 2018 & 2026

  • 5.2 Angina Pectoris Treatment Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Angina Pectoris Treatment Market: Application Analysis

  • 6.1 Angina Pectoris Treatment Application Market Share Analysis, 2018 & 2026

  • 6.2 Angina Pectoris Treatment Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Clinic

    • 6.3.3 Other

7 Angina Pectoris Treatment Market: Regional Analysis

  • 7.1 Angina Pectoris Treatment Regional Market Share Analysis, 2018 & 2026

  • 7.2 Angina Pectoris Treatment Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Bristol-Myers Squibb Company

    • 9.1.1 Bristol-Myers Squibb Company Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Bayer AG

    • 9.2.1 Bayer AG Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Astra Zeneca plc

    • 9.3.1 Astra Zeneca plc Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Abbott Laboratories Inc.

    • 9.4.1 Abbott Laboratories Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 F. Hoffmann-La Roche Ltd

    • 9.5.1 F. Hoffmann-La Roche Ltd Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Forest Laboratories Inc

    • 9.6.1 Forest Laboratories Inc Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Sanofi SA

    • 9.7.1 Sanofi SA Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Pfizer Inc.

    • 9.8.1 Pfizer Inc. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Gilead Sciences, Inc

    • 9.9.1 Gilead Sciences, Inc Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Novartis AG

    • 9.10.1 Novartis AG Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 GlaxoSmithKline plc

    • 9.11.1 GlaxoSmithKline plc Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 71 Figures and 165 Tables)

  • Figure Antiplatelet agents Angina Pectoris Treatment market, 2015 - 2026 (USD Million)

  • Figure Beta-adrenergic blocking agents Angina Pectoris Treatment market, 2015 - 2026 (USD Million)

  • Figure Calcium channel blockers Angina Pectoris Treatment market, 2015 - 2026 (USD Million)

  • Figure Short & Long – acting Nitroglycerines Angina Pectoris Treatment market, 2015 - 2026 (USD Million)

  • Figure Angiotensin-converting enzyme (ACE) inhibitors Angina Pectoris Treatment market, 2015 - 2026 (USD Million)

  • Figure Anti-ischemic agents Angina Pectoris Treatment market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Angina Pectoris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table North America Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table North America Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table North America Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Canada Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Canada Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Europe Angina Pectoris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Europe Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Europe Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Europe Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Germany Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Germany Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table France Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table France Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Italy Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Italy Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Spain Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Spain Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angina Pectoris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table China Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table China Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Japan Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Japan Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table India Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table India Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Angina Pectoris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table MEA Angina Pectoris Treatment market, by country, 2015 - 2026 (USD Million)

  • Table MEA Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table MEA Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table MEA Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Angina Pectoris Treatment market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Angina Pectoris Treatment market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Angina Pectoris Treatment market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astra Zeneca plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Forest Laboratories Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gilead Sciences, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top